×
About 822 results

ALLMedicine™ Plasmablastic Lymphoma Center

Research & Reviews  409 results

Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recur...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899902
Medicine Rong C, Sheng L et. al.

Feb 20th, 2021 - No standard guideline has been established for the treatment of plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemotherapy and show resistance to commonly used cytostatic drugs. We prese...

Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?-Pote...
https://doi.org/10.1111/ejh.13584
European Journal of Haematology; Roché P, Venton G et. al.

Jan 20th, 2021 - Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?-Potential therapeutic applications.|2021|Roché P,Venton G,Berda-Haddad Y,Fritz S,Ivanov V,|

The Emerging Treatment Options of Plasmablastic Lymphoma: Analysis of 173 Individual Pa...
https://doi.org/10.1016/j.clml.2020.11.025
Clinical Lymphoma, Myeloma & Leukemia; Makady NF, Ramzy D et. al.

Jan 9th, 2021 - Plasmablastic lymphoma (PBL) is a newly recognized aggressive subtype of non-Hodgkin lymphoma. Its rarity hinders testing effective treatment options in clinical trials. We conducted a systematic review of PubMed and our internal records to retrie...

Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas.
https://doi.org/10.3324/haematol.2020.267294
Haematologica Leeman-Neill RJ, Soderquist CR et. al.

Dec 10th, 2020 - Plasmablastic lymphoma (PBL) is a rare and clinically aggressive neoplasm that typically occurs in immunocompromised individuals, including those with HIV infection and solid organ allograft recipients. Most prior studies have focused on delineati...

HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience o...
https://doi.org/10.1097/01.aids.0000721216.82960.36
AIDS (London, England);

Oct 26th, 2020 - HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients: Erratum.|2020||

see more →

Clinicaltrials.gov  409 results

Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recur...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899902
Medicine Rong C, Sheng L et. al.

Feb 20th, 2021 - No standard guideline has been established for the treatment of plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemotherapy and show resistance to commonly used cytostatic drugs. We prese...

Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?-Pote...
https://doi.org/10.1111/ejh.13584
European Journal of Haematology; Roché P, Venton G et. al.

Jan 20th, 2021 - Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?-Potential therapeutic applications.|2021|Roché P,Venton G,Berda-Haddad Y,Fritz S,Ivanov V,|

The Emerging Treatment Options of Plasmablastic Lymphoma: Analysis of 173 Individual Pa...
https://doi.org/10.1016/j.clml.2020.11.025
Clinical Lymphoma, Myeloma & Leukemia; Makady NF, Ramzy D et. al.

Jan 9th, 2021 - Plasmablastic lymphoma (PBL) is a newly recognized aggressive subtype of non-Hodgkin lymphoma. Its rarity hinders testing effective treatment options in clinical trials. We conducted a systematic review of PubMed and our internal records to retrie...

Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas.
https://doi.org/10.3324/haematol.2020.267294
Haematologica Leeman-Neill RJ, Soderquist CR et. al.

Dec 10th, 2020 - Plasmablastic lymphoma (PBL) is a rare and clinically aggressive neoplasm that typically occurs in immunocompromised individuals, including those with HIV infection and solid organ allograft recipients. Most prior studies have focused on delineati...

HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience o...
https://doi.org/10.1097/01.aids.0000721216.82960.36
AIDS (London, England);

Oct 26th, 2020 - HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients: Erratum.|2020||

see more →

News  4 results

Painless Nodule on the Leg
https://www.mdedge.com/dermatology/article/202418/infectious-diseases/painless-nodule-leg?channel=234
Theodora K. Karagounis, MD, Veronica Rotemberg, MD, PhD

Jun 6th, 2019 - The Diagnosis: Plasmablastic Lymphoma Histopathologic examination revealed a diffuse dense proliferation of large, atypical, and pleomorphic mononuclear cells with prominent nucleoli and many mitotic figures representing plasmacytoid cells in the.

Community Oncology Podcast: T-DM1 in HER-2 positive breast cancer
https://www.mdedge.com/hematology-oncology/article/58485/breast-cancer/community-oncology-podcast-t-dm1-her-2-positive

Mar 31st, 2013 - Editor-in-Chief Dr. David Henry highlights articles on T-DM1 for advanced HER2-positive breast cancer and an original research report from US Oncology on treatment patterns in women with HER2-/HR-positive breast cancer.

Plasmablastic lymphoma in the ileum
https://www.mdedge.com/hematology-oncology/article/58466/lymphoma-plasma-cell-disorders/plasmablastic-lymphoma-ileum
Ahmad F. Maatouk, MD

Mar 1st, 2013 - Plasmablastic lymphoma (PBL) is classified by the World Health Organization as a distinct type of diffuse large B-cell non-Hodgkin lymphoma, which is characterized by plasma cell differentiation and immunoblastic cell morphology. 1 PBL usually deve.

Plasmablastic lymphoma presenting as proptosis and impending visual loss
https://www.mdedge.com/hematology-oncology/article/58425/lymphoma-plasma-cell-disorders/plasmablastic-lymphoma-presenting
Mihaela Vatca, MD, Katherine Robbins, MD et. al.

Jan 1st, 2013 - A 40-year-old Hispanic man with an unremarkable medical history presented to the emergency department with sudden onset swelling of and loss of vision in the left eye. His symptoms had initially developed 3 months before his presentation and were.

see more →